Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

NCT05716035 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Myasthenia Gravis, Generalized

Interventions

DRUG: Tocilizumab Injection

Sponsor

Tang-Du Hospital